GlaxoSmithKline Inc.
Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
---|---|---|
Advocacy as it relates to Patended Medicines Pricing Review Board and its potential impact on BC's Life Sciences and Research Community
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Advanced Education, Economic Development and Trade, Health, Industry
|
Advocacy related to pharmaceutical and health sciences research
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Advanced Education, COVID-19, Health, Hospitals, Industry
|
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19, Emergency Preparedness, Government Procurement, Health, Hospitals
|
Discussions related to pharmaceutical, vaccine and other health policy generally
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
COVID-19
|